EMCURE PHARMACEUTICALS L (EMCURE)

NSE: ₹1,745.20
BSE: ₹1,744.70
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 1,815.14 2,001.98 1,962.63 2,116.25 2,100.54 2,269.82 2,363.48 2,469.70
YOY Revenue Growth % - - - - 15.72% 13.38% 20.42% 16.7%
Other Income 23.44 35.65 3.90 4.45 3.70 3.12 1.85 3.99
Total Income 1,838.58 2,037.64 1,966.53 2,120.70 2,104.23 2,272.95 2,365.33 2,473.70
Total Expenses + 1,631.17 1,764.23 1,736.61 1,849.71 1,809.98 1,931.53 2,013.39 2,142.82
Cost of Materials Consumed 331.72 391.49 399.83 403.87 432.50 420.46 421.23 418.58
Employee Benefit Expense 350.40 355.59 366.93 373.37 393.47 384.62 387.33 386.78
Other Expenses 445.32 476.85 458.36 448.37 488.28 520.19 520.98 600.29
Operating Profit 183.97 237.76 226.02 266.54 290.56 338.29 350.09 326.88
OPM % 10.1% 11.9% 11.5% 12.6% 13.8% 14.9% 14.8% 13.2%
Profit Before Tax + 207.41 273.41 229.92 260.61 290.76 341.42 313.79 341.18
Tax Expense 54.82 71.86 73.83 63.38 75.97 90.05 82.42 97.44
Tax % 26.4% 26.3% 32.1% 24.3% 26.1% 26.4% 26.3% 28.6%
Profit After Tax 152.59 201.55 156.09 197.24 214.79 251.37 231.37 243.74
EPS (Basic) 7.95 10.33 8.12 9.97 10.92 12.85 12.16 12.84

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025
Revenue from Operations 9,203.54 7,896.00
YOY Revenue Growth % 16.56% -
Other Income 12.66 67.26
Total Income 9,216.20 7,963.26
Total Expenses + 7,897.71 6,981.53
Cost of Materials Consumed 1,692.77 1,526.90
Employee Benefit Expense 1,552.20 1,446.29
Other Expenses 2,129.73 1,828.72
Operating Profit 1,305.83 914.47
OPM % 14.2% 11.6%
Profit Before Exceptional 1,318.49 981.73
Exceptional Items -31.35 -10.38
Profit Before Tax + 1,287.14 971.35
Tax Expense 345.87 263.88
Tax % 26.9% 27.2%
Profit After Tax 941.27 707.47
EPS (Basic) 48.77 36.43

Balance Sheet

Particulars Mar 2026 Mar 2025
ASSETS
Non-Current Assets + 3,903.45 3,582.82
Property, Plant & Equipment 1,959.93 1,953.60
Capital Work in Progress 172.06 124.06
Non-Current Investments 19.70 19.34
Goodwill 414.26 367.78
Other Intangible Assets 945.03 875.36
Current Assets + 5,709.03 4,649.90
Inventories 2,397.87 1,931.81
Trade Receivables 2,562.66 2,002.24
Cash and Cash Equivalents 136.66 155.54
Current Investments 0.00 76.04
LIABILITIES & EQUITY
Total Equity 4,976.67 4,641.55
Equity Share Capital 189.59 189.48
Other Equity 4,760.44 4,256.70
Non-Current Liabilities 723.57 922.90
Current Liabilities 3,912.24 2,668.27
Total Liabilities 4,635.81 3,591.17

Cash Flow Statement

Particulars Mar 2026 Mar 2025
Cash from Operating Activities 943.55 851.71
Cash from Investing Activities -1,193.06 -94.00
Cash from Financing Activities 343.43 -813.96
Net Increase/Decrease in Cash 112.08 -58.30